Annovis Bio Receives FDA Approval to Transition to New Crystal Form of Buntanetap
July 16, 2024 08:00 ET
|
Annovis Bio, Inc.
MALVERN, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...
Catapult Learning and Praxis Partner on Program to Equip New Teachers With Skills in Math Instruction and Core Competencies
March 12, 2024 08:27 ET
|
Catapult Learning
CATAPULT LEARNING AND PRAXIS PARTNER ON PROGRAM TO EQUIP NEW TEACHERS WITH SKILLS IN MATH INSTRUCTION AND CORE COMPETENCIES
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
March 05, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
Data shows reduction of microglia activation and improvement in behavior in rodent models of Alzheimer’s disease (AD) and Parkinson’s disease (PD)Nasal anti-CD3 reduced hemorrhage and edema that...
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
December 14, 2023 08:00 ET
|
Rani Therapeutics, LLC
- Transenteric delivery of incretin triagonist of GLP-1, GIP, glucagon receptors elicits rapid weight loss in animal study – - Preclinical data support the potential for the RaniPill platform...
Brain Implants Market Size Worth $17.64 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 10, 2023 07:51 ET
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Neuroscience and neurotechnology are advancing rapidly, pushing medical science to new limits, driving the growth of the market, as neurological...
Immuneering Announces Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program; Accelerates Study Timeline
April 18, 2023 09:00 ET
|
Immuneering Corporation
Data presented at AACR Annual Meeting support IMM-1-104's potential to address a broad population of patients with RAS mutant tumorsIMM-1-104 well tolerated with no dose limiting toxicities (DLTs) or...
Catapult Learning Selected by Mississippi Department of Education to Provide Statewide Professional Development and Coaching Services
February 08, 2023 08:15 ET
|
Catapult Learning
PHILADELPHIA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Catapult Learning, a provider of intervention programs for students and professional development solutions for teachers in K-12 schools, announced its...
2 Day Virtual Credit Risk Measurement and Management Course: October 17-18, 2022
October 03, 2022 04:03 ET
|
Research and Markets
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Credit Risk Measurement and Management" training has been added to ResearchAndMarkets.com's offering. The course will give you detailed knowledge of...
Aeterna Zentaris Announces Shareholder Approval of Share Consolidation
July 15, 2022 16:15 ET
|
Aeterna Zentaris Inc
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and...
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
June 21, 2022 16:01 ET
|
Aeterna Zentaris Inc
- Vote to approve share consolidation adjourned to July 6, 2022 TORONTO, ONTARIO, June 21, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...